| MeSH term | MeSH ID | Detail |
|---|---|---|
| Gram-Negative Bacterial Infections | D016905 | 16 associated lipids |
| Angiomatosis, Bacillary | D016917 | 2 associated lipids |
| Meningitis, Bacterial | D016920 | 6 associated lipids |
| Common Variable Immunodeficiency | D017074 | 4 associated lipids |
| AIDS-Related Opportunistic Infections | D017088 | 9 associated lipids |
| IgA Deficiency | D017098 | 2 associated lipids |
| Liver Failure, Acute | D017114 | 11 associated lipids |
| Skin Diseases, Bacterial | D017192 | 8 associated lipids |
| Dermatitis, Phototoxic | D017484 | 4 associated lipids |
| Pityriasis Rosea | D017515 | 3 associated lipids |
| Cutaneous Fistula | D017577 | 1 associated lipids |
| Kleine-Levin Syndrome | D017593 | 1 associated lipids |
| Periodontal Attachment Loss | D017622 | 7 associated lipids |
| Soft Tissue Injuries | D017695 | 2 associated lipids |
| Community-Acquired Infections | D017714 | 8 associated lipids |
| Cytomegalovirus Retinitis | D017726 | 2 associated lipids |
| Tuberculosis, Multidrug-Resistant | D018088 | 6 associated lipids |
| Cardiovascular Abnormalities | D018376 | 2 associated lipids |
| Pneumonia, Bacterial | D018410 | 16 associated lipids |
| Soft Tissue Infections | D018461 | 2 associated lipids |
| Ventricular Dysfunction, Left | D018487 | 33 associated lipids |
| Cryptogenic Organizing Pneumonia | D018549 | 3 associated lipids |
| Carcinoma, Lewis Lung | D018827 | 22 associated lipids |
| Gingival Overgrowth | D019214 | 7 associated lipids |
| Tooth, Nonvital | D019553 | 2 associated lipids |
| alpha 1-Antitrypsin Deficiency | D019896 | 3 associated lipids |
| Genetic Predisposition to Disease | D020022 | 24 associated lipids |
| Neurotoxicity Syndromes | D020258 | 34 associated lipids |
| Central Nervous System Protozoal Infections | D020808 | 3 associated lipids |
| Epilepsy, Partial, Motor | D020938 | 1 associated lipids |
| Chlamydophila Infections | D023521 | 4 associated lipids |
| Desulfovibrionaceae Infections | D045824 | 5 associated lipids |
| Renal Insufficiency | D051437 | 8 associated lipids |
| Immune Reconstitution Inflammatory Syndrome | D054019 | 1 associated lipids |
| Buruli Ulcer | D054312 | 1 associated lipids |
| Extensively Drug-Resistant Tuberculosis | D054908 | 1 associated lipids |
| Leprosy, Paucibacillary | D056005 | 2 associated lipids |
| Upper Extremity Deep Vein Thrombosis | D056824 | 1 associated lipids |
| Acute Kidney Injury | D058186 | 34 associated lipids |
| Plaque, Atherosclerotic | D058226 | 7 associated lipids |
| Sacroiliitis | D058566 | 1 associated lipids |
| Chlamydial Pneumonia | D061387 | 2 associated lipids |
clarithromycin
clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.
Cross Reference
Introduction
To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with clarithromycin?
clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (63)
- J. Antimicrob. Chemother. (56)
- J. Clin. Microbiol. (39)
- Others (258)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with clarithromycin
PubChem Associated disorders and diseases
What pathways are associated with clarithromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with clarithromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- J. Antimicrob. Chemother. (25)
- Antimicrob. Agents Chemother. (20)
- J. Clin. Microbiol. (9)
- Others (66)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with clarithromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with clarithromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (5)
- Drug Metab. Dispos. (1)
- FEMS Immunol. Med. Microbiol. (1)
- Others (5)
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with clarithromycin?
Related references are published most in these journals:
- J. Antimicrob. Chemother. (20)
- Antimicrob. Agents Chemother. (17)
- J. Clin. Microbiol. (13)
- Others (57)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with clarithromycin?
Mouse Model
Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).
Knock-out
Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).
Experimental Pneumococcal Meningitis
Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with clarithromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Walkey AJ and Wiener RS | Macrolide antibiotics and survival in patients with acute lung injury. | 2012 | Chest | pmid:22116799 |
| Reva I et al. | Virulence genotypes and drug resistance of Helicobacter pylori from Vladivostok, Russia: another feature in the Far East. | 2012 | Microbiol. Immunol. | pmid:22211953 |
| Park SJ et al. | Fulminant and Fatal Multiple Organ Failure in a 12-Year-Old Boy With Mycoplasma pneumoniae Infection. | 2012 | Allergy Asthma Immunol Res | pmid:22211173 |
| Falkinham JO et al. | Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria. | 2012 | Tuberculosis (Edinb) | pmid:22209468 |
| Ohtani M et al. | Amino acid and vitamin supplementation improved health conditions in elderly participants. | 2012 | J Clin Biochem Nutr | pmid:22448099 |
| Goswami S et al. | Anti-Helicobacter pylori potential of artemisinin and its derivatives. | 2012 | Antimicrob. Agents Chemother. | pmid:22687518 |
| Cuadrado-LavÃn A et al. | Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial. | 2012 | J. Antimicrob. Chemother. | pmid:22687889 |
| Nseir W et al. | Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study. | 2012 | Aliment. Pharmacol. Ther. | pmid:22646167 |
| Zaater MF et al. | Determination and stability assessment of clarithromycin in human plasma using RP-LC with electrochemical detection. | 2012 | J Chromatogr Sci | pmid:22647394 |
| Choi HS et al. | Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection. | 2012 | World J. Gastroenterol. | pmid:22654429 |
| Majima Y et al. | Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp. | 2012 | Auris Nasus Larynx | pmid:21636230 |
| Gisbert JP and Calvet X | Review article: rifabutin in the treatment of refractory Helicobacter pylori infection. | 2012 | Aliment. Pharmacol. Ther. | pmid:22129228 |
| Nujić K et al. | Valosin containing protein (VCP) interacts with macrolide antibiotics without mediating their anti-inflammatory activities. | 2012 | Eur. J. Pharmacol. | pmid:22209877 |
| Hiramatsu M et al. | Risk factors that affect the surgical outcome in the management of focal bronchiectasis in a developed country. | 2012 | Ann. Thorac. Surg. | pmid:22119119 |
| Chan A et al. | A case of wrist tenosynovitis caused by Mycobacterium kansasii in a renal transplant recipient. | 2012 | Transpl Infect Dis | pmid:22822725 |
| Koh WJ et al. | Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease. | 2012 | Am. J. Respir. Crit. Care Med. | pmid:22878282 |
| Maurer FP et al. | Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41). | 2012 | J. Antimicrob. Chemother. | pmid:22833642 |
| Kanazu T et al. | Investigation of drug-drug interaction via mechanism-based inhibition of cytochrome P450 3A by macrolides in dexamethasone-treated female rats. | 2012 | Biopharm Drug Dispos | pmid:22447511 |
| Togami K et al. | Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells. | 2012 | Pharmazie | pmid:22764569 |
| Zullo A et al. | Role of gastritis pattern on Helicobacter pylori eradication. | 2012 | Intern Emerg Med | pmid:22105372 |
| Fujioka T et al. | A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan. | 2012 | J. Gastroenterol. | pmid:22065160 |
| Park HG et al. | Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients. | 2012 | Aliment. Pharmacol. Ther. | pmid:22066530 |
| Chung JW et al. | Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance. | 2012 | J. Gastroenterol. Hepatol. | pmid:21793912 |
| Qian J et al. | Levofloxacin-containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China. | 2012 | Helicobacter | pmid:23067317 |
| Liang J et al. | Helicobacter pylori eradication with ecabet sodium, omeprazole, amoxicillin, and clarithromycin versus bismuth, omeprazole, amoxicillin, and clarithromycin quadruple therapy: a randomized, open-label, phase IV trial. | 2012 | Helicobacter | pmid:23066868 |
| Erol E et al. | Antibiotic susceptibility patterns of Crossiella equi and Amycolatopsis species causing nocardioform placentitis in horses. | 2012 | J. Vet. Diagn. Invest. | pmid:23051830 |
| Dalkmann P et al. | Accumulation of pharmaceuticals, Enterococcus, and resistance genes in soils irrigated with wastewater for zero to 100 years in central Mexico. | 2012 | PLoS ONE | pmid:23049795 |
| Kurugol Z et al. | Severe Hemolytic Anemia Associated with Mild Pneumonia Caused by Mycoplasma pneumonia. | 2012 | Case Rep Med | pmid:23049568 |
| Deng ZH et al. | Influence of Helicobacter pylori infection on ghrelin levels in children. | 2012 | World J. Gastroenterol. | pmid:23049220 |
| Malfertheiner P et al. | Helicobacter pylori: clinical management. | 2012 | Curr. Opin. Gastroenterol. | pmid:23010682 |
| Tepes B et al. | Treatment of Helicobacter pylori infection 2012. | 2012 | Helicobacter | pmid:22958154 |
| Saracino IM et al. | High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy. | 2012 | J Gastrointestin Liver Dis | pmid:23256118 |
| Tsay FW et al. | Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan. | 2012 | J. Gastroenterol. Hepatol. | pmid:21871025 |
| Spyridaki A et al. | Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study. | 2012 | Antimicrob. Agents Chemother. | pmid:22564837 |
| Cajigas-Pezo D et al. | [Swelling of right knee in an immunologically compromised patient]. | 2012 | Enferm. Infecc. Microbiol. Clin. | pmid:22521279 |
| McCallum GB et al. | Antibiotics for persistent cough or wheeze following acute bronchiolitis in children. | 2012 | Cochrane Database Syst Rev | pmid:23235681 |
| Boyanova L et al. | Numerous risk factors for Helicobacter pylori antibiotic resistance revealed by extended anamnesis: a Bulgarian study. | 2012 | J. Med. Microbiol. | pmid:21873378 |
| Hu FL et al. | [Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study]. | 2012 | Zhonghua Yi Xue Za Zhi | pmid:22781295 |
| Kotsaki A and Giamarellos-Bourboulis EJ | Emerging drugs for the treatment of sepsis. | 2012 | Expert Opin Emerg Drugs | pmid:22780561 |
| KurinÄiÄ M et al. | Epigallocatechin gallate as a modulator of Campylobacter resistance to macrolide antibiotics. | 2012 | Int. J. Antimicrob. Agents | pmid:22999765 |
| Fiorini G et al. | Newer agents for Helicobacter pylori eradication. | 2012 | Clin Exp Gastroenterol | pmid:22767998 |
| Whittemore KR and Cohen M | Imaging and review of a large pre-auricular pilomatrixoma in a child. | 2012 | World J Radiol | pmid:22761984 |
| Kudo T et al. | Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin- and metronidazole-containing triple therapy for Helicobacter pylori: a pilot study. | 2012 | Helicobacter | pmid:22759327 |
| Roccarina D et al. | Different Antibiotic No Culture Eradicating (DANCE) strategy: an easy way to manage H. pylori eradication. | 2012 | Dig Liver Dis | pmid:22743557 |
| Tursi A et al. | Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection. | 2012 | J Gastrointestin Liver Dis | pmid:22720300 |
| Huang J et al. | [A 10-day sequential therapy for eradication of Helicobacter pylori infection in children]. | 2012 | Zhonghua Er Ke Za Zhi | pmid:23158730 |
| Tatar EÇ et al. | Prevalence of biofilms and their response to medical treatment in chronic rhinosinusitis without polyps. | 2012 | Otolaryngol Head Neck Surg | pmid:22241786 |
| Birteksöz-Tan AS and Zeybek Z | Postantibiotic effect of various antibiotics on Legionella pneumophila strains isolated from water systems. | 2012 | Folia Microbiol. (Praha) | pmid:22627604 |
| Chang WJ et al. | Successful salvage treatment of steroid-refractory bronchiolar COP with low-dose macrolides. | 2012 | Pathol. Int. | pmid:22243785 |
| Burt HJ et al. | Progress curve mechanistic modeling approach for assessing time-dependent inhibition of CYP3A4. | 2012 | Drug Metab. Dispos. | pmid:22621802 |
| Lismond A et al. | Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium. | 2012 | Int. J. Antimicrob. Agents | pmid:22245497 |
| Bermudez LE et al. | Identification of (+)-erythro-mefloquine as an active enantiomer with greater efficacy than mefloquine against Mycobacterium avium infection in mice. | 2012 | Antimicrob. Agents Chemother. | pmid:22615290 |
| Agarwal E et al. | Efficacy of local drug delivery of 0.5% clarithromycin gel as an adjunct to non-surgical periodontal therapy in the treatment of current smokers with chronic periodontitis: a randomized controlled clinical trial. | 2012 | J. Periodontol. | pmid:22248223 |
| Khan A et al. | Antibiotic resistance and cagA gene correlation: a looming crisis of Helicobacter pylori. | 2012 | World J. Gastroenterol. | pmid:22611319 |
| Szałek E et al. | Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not? | 2012 | Pharmacol Rep | pmid:23406766 |
| Takeshima F et al. | Successful management of cap polyposis with eradication of Helicobacter pylori relapsing 15 years after remission on steroid therapy. | 2012 | Intern. Med. | pmid:22333383 |
| Lawal TO et al. | Combination studies of Eucalyptus torelliana F. Muell. leaf extracts and clarithromycin on Helicobacter pylori. | 2012 | Phytother Res | pmid:22318891 |
| Slater CM and Ford AC | Treatment of Helicobacter pylori in Latin America. | 2012 | Lancet | pmid:22305216 |
| Gatta L et al. | Treatment of Helicobacter pylori in Latin America. | 2012 | Lancet | pmid:22305217 |
| Dicicco M et al. | Efficacy of clarithromycin on biofilm formation of methicillin-resistant Staphylococcus pseudintermedius. | 2012 | BMC Vet. Res. | pmid:23171620 |
| Graham DY and Trespalacios AA | Treatment of Helicobacter pylori in Latin America. | 2012 | Lancet | pmid:22305218 |
| Prasad R | Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies. | 2012 | Lung India | pmid:22628931 |
| Alfakry H et al. | The association of serum neutrophil markers and acute coronary syndrome. | 2012 | Scand. J. Immunol. | pmid:22537345 |
| Shaifali I et al. | Antibiotic susceptibility patterns of urinary pathogens in female outpatients. | 2012 | N Am J Med Sci | pmid:22536558 |
| Gisbert JP | Rescue Therapy for Helicobacter pylori Infection 2012. | 2012 | Gastroenterol Res Pract | pmid:22536225 |
| Lee RP et al. | Mycobacterium chelonae infection after total knee arthroplasty: a case report. | 2012 | J Orthop Surg (Hong Kong) | pmid:22535831 |
| Shaaban HS et al. | Mycobacterium chelonae infection of the parotid gland. | 2012 | J Glob Infect Dis | pmid:22529633 |
| Karlgren M et al. | Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. | 2012 | J. Med. Chem. | pmid:22541068 |
| Monno R et al. | Helicobacter pylori clarithromycin resistance detected by Etest and TaqMan real-time polymerase chain reaction: a comparative study. | 2012 | APMIS | pmid:22882260 |
| Pandya GJ et al. | Unilateral lobar pulmonary edema. | 2012 | J Assoc Physicians India | pmid:23547417 |
| Fakheri H et al. | A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial. | 2012 | Helicobacter | pmid:22221615 |
| Georgopoulos S et al. | Evaluation of a four-drug, three-antibiotic, nonbismuth-containing "concomitant" therapy as first-line Helicobacter pylori eradication regimen in Greece. | 2012 | Helicobacter | pmid:22221616 |
| Senhorinho GN et al. | Occurrence and antimicrobial susceptibility of Porphyromonas spp. and Fusobacterium spp. in dogs with and without periodontitis. | 2012 | Anaerobe | pmid:22609780 |
| Komatsu S et al. | Clarithromycin enhances bortezomib-induced cytotoxicity via endoplasmic reticulum stress-mediated CHOP (GADD153) induction and autophagy in breast cancer cells. | 2012 | Int. J. Oncol. | pmid:22200786 |
| Matsuzaki J et al. | Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies. | 2012 | Antimicrob. Agents Chemother. | pmid:22203601 |
| Adrjanowicz K et al. | Molecular dynamics in supercooled liquid and glassy states of antibiotics: azithromycin, clarithromycin and roxithromycin studied by dielectric spectroscopy. Advantages given by the amorphous state. | 2012 | Mol. Pharm. | pmid:22540343 |
| Kobashi Y et al. | Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period. | 2012 | J. Infect. Chemother. | pmid:22205543 |
| Lin Z and Will Y | Evaluation of drugs with specific organ toxicities in organ-specific cell lines. | 2012 | Toxicol. Sci. | pmid:22166485 |
| Onoe H et al. | Buruli ulcer accompanied by pain in a Japanese patient. | 2012 | J. Dermatol. | pmid:22168180 |
| Lulitanond A et al. | Prevalence of β-lactamase-negative ampicillin-resistant haemophilus influenzae isolated from patients of a teaching hospital in Thailand. | 2012 | Jpn. J. Infect. Dis. | pmid:22446118 |
| Liang Y et al. | Epidemiological and molecular characteristics of clinical isolates of Streptococcus pyogenes collected between 2005 and 2008 from Chinese children. | 2012 | J. Med. Microbiol. | pmid:22442290 |
| Gomez-Abreo D et al. | [Chronic necrotizing pulmonary aspergillosis following an infection by Mycobacterium malmoense]. | 2012 | Rev Mal Respir | pmid:22440310 |
| Guillot S et al. | Macrolide-resistant Bordetella pertussis infection in newborn girl, France. | 2012 | Emerging Infect. Dis. | pmid:22608348 |
| Lee JH et al. | A nanohybrid system for taste masking of sildenafil. | 2012 | Int J Nanomedicine | pmid:22619517 |
| Khavinson VKh et al. | Peptidergic regulation of expression of genes encoding antioxidant and anti-inflammatory proteins. | 2012 | Bull. Exp. Biol. Med. | pmid:22803148 |
| Lachter J et al. | Yellow brain culinary-medicinal mushroom, Tremella mesenterica Ritz.:Fr. (higher Basidiomycetes), is subjectively but not objectively effective for eradication of Helicobacter pylori: a prospective controlled trial. | 2012 | Int J Med Mushrooms | pmid:22339708 |
| Molina-Infante J et al. | Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains. | 2012 | Helicobacter | pmid:22759326 |
| Kongchayanun C et al. | Pilot studies to identify the optimum duration of concomitant Helicobacter pylori eradication therapy in Thailand. | 2012 | Helicobacter | pmid:22759328 |
| Song JY et al. | Case series of mycobacterium abscessus infections associated with a trigger point injection and epidural block at a rural clinic. | 2012 | Epidemiol Health | pmid:22323979 |
| Nguyen TV et al. | Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance. | 2012 | Helicobacter | pmid:22759333 |
| Hirata Y et al. | Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan. | 2012 | Int. J. Antimicrob. Agents | pmid:22321702 |
| NiziÄ T et al. | Solitary erythema migrans in children: comparison of treatment with clarithromycin and amoxicillin. | 2012 | Wien. Klin. Wochenschr. | pmid:22760494 |
| Yokota S et al. | Clarithromycin suppresses human respiratory syncytial virus infection-induced Streptococcus pneumoniae adhesion and cytokine production in a pulmonary epithelial cell line. | 2012 | Mediators Inflamm. | pmid:22761540 |
| Brown-Elliott BA et al. | Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. | 2012 | Clin. Microbiol. Rev. | pmid:22763637 |
| Pereyre S et al. | Clonal spread of Mycoplasma pneumoniae in primary school, Bordeaux, France. | 2012 | Emerging Infect. Dis. | pmid:22305177 |
| Butler CC et al. | Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. | 2012 | BMJ | pmid:22302780 |
| Carlos CA et al. | Mycobacterial infection identified with broad-range PCR amplification and suspension array identification. | 2012 | J. Cutan. Pathol. | pmid:22764735 |
| Anand TD et al. | Superantigen profiles of emm and emm-like typeable and nontypeable pharyngeal streptococcal isolates of South India. | 2012 | Ann. Clin. Microbiol. Antimicrob. | pmid:22296671 |
| Tonkic A et al. | Time trends of primary antibiotic resistance of Helicobacter pylori isolates in Southern Croatia. | 2012 | J Chemother | pmid:22759765 |
| Correia M et al. | Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization. | 2012 | PLoS ONE | pmid:22529974 |